AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Tacrolimus in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Tacrolimus Sandoz 1 mg Capsule Capsule | B4-1894 | Novartis Nigeria Limited | active | 6 May 2026 |
| Tacrolimus Sandoz 5 mg Capsule Capsule | B4-1892 | Novartis Nigeria Limited | active | 6 May 2026 |
Tacrolimus — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Tacrolimus, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Tacrolimus registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.